Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 7,329 | 7,621 | 9,645 | 8,177 | 9,361 |
| Operating Income | -7,329 | -7,621 | -9,645 | -8,177 | -9,361 |
| Other Income | 221 | 151 | 79 | 41 | 94 |
| Pre-tax Income | -7,108 | -7,470 | -9,566 | -8,136 | -9,267 |
| Net Income Continuous | -7,108 | -7,470 | -9,566 | -8,136 | -9,267 |
| Net Income | $-7,108 | $-7,470 | $-9,566 | $-8,136 | $-9,267 |
| EPS Basic Total Ops | -0.10 | -0.13 | -0.21 | -0.23 | -0.33 |
| EPS Basic Continuous Ops | -0.10 | -0.13 | -0.21 | -0.23 | -0.33 |
| EPS Diluted Total Ops | -0.10 | -0.13 | -0.21 | -0.23 | -0.33 |
| EPS Diluted Continuous Ops | -0.10 | -0.13 | -0.21 | -0.23 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.10 | -0.13 | -0.21 | N/A | N/A |
| EBITDA(a) | $-7,329 | $-7,621 | $-9,645 | $-8,177 | $-9,361 |